Transaxillary Transcatheter Aortic Valve Replacement With Pure Echocardiography Guidance
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• symptomatic severe AS determined by echocardiography and Doppler that requiring aortic valve replacement, defined as: mean gradient ≥40 mmHg, peak aortic velocity ≥4 m/s, and aortic valve area (AVA) ≤1 cm2 (or an indexed AVA ≤0.6 cm2/m2)
• suitable for Transaxillary TAVR
Locations
Other Locations
China
Fuwai Hospital
RECRUITING
Beijing
Contact Information
Primary
Xiangbin Pan, MD
panxiangbin@fuwaihospital.org
+8688396666
Backup
Xu Wang, MD
+86 88396655
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 20
Treatments
Experimental: Echo guided TAVR
Patients received Echocardiography guided TAVR
Related Therapeutic Areas
Sponsors
Leads: Chinese Academy of Medical Sciences, Fuwai Hospital